Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2015

View Archived Issues

Roche reflects on accomplishments of second quarter 2015

Promising advances on the way towards a universal flu vaccine

3SBio acquires small molecule manufacturer Zhejiang Wansheng Pharmaceutical

Grant supports development of Minomic's antibody technology

Horizon collaborates with Fox Chase to study Actimmune with PD-1/PD-L1 inhibitors for cancer

Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca

Phase III extension studies show long-term benefit of NX-1207 in BPH

FDA approves second phase II protocol for MN-001 in NASH

Shire reviews milestones of second quarter 2015

Boehringer Ingelheim ends BACE inhibitor collaboration and license agreement with Vitae

Creatine kinase levels are associated to ALS prognosis

Biomarker may speed diagnosis of oral squamous cell carcinoma

Avraham Pharmaceuticals reports results from phase IIb trial of ladostigil in MCI

Regeneron and Sanofi form immuno-oncology collaboration

FDA grants breakthrough therapy designation to lenvatinib for renal cell carcinoma

Azedra receives breakthrough therapy designation for pheochromocytoma and paraganglioma

Preliminary phase II results presented for VAC-3S HIV vaccine

EMA accepts filing of MAA for reslizumab

FDA accepts for review CSL Behring's BLA for rVIII-SingleChain therapy

Mallinckrodt to divest its contrast media business to Guerbet

Rosetta Genomics' oncogene mutation assay OncoGxSelect approved for clinical use

Nanjing Sanhome patent reports anti-HCV agents

Aurigene Discovery discloses RORgamma receptor ligands

KTandG Life Sciences patents NQO1 modulators

FDA accepts for review NDA for grazoprevir/elbasvir for hepatitis C

Hikma to acquire Roxane Laboratories

Takeda reports identification of PI3K inhibitors

Sanofi's first LixiLan phase III study meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...